275 related articles for article (PubMed ID: 27669362)
1. Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor.
Crocchiolo R; Giordano L; Rimondo A; Bologna M; Sarina B; Morabito L; Bramanti S; Castagna L; Mineri R
J Clin Virol; 2016 Nov; 84():24-26. PubMed ID: 27669362
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the shedding of three β-herpesviruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up.
Dzieciatkowski T; Tomaszewska A; Przybylski M; Rusicka P; Basak GW; Jedrzejczak WW; Wroblewska M; Halaburda K
J Clin Virol; 2016 Mar; 76():30-5. PubMed ID: 26809130
[TBL] [Abstract][Full Text] [Related]
3. An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation.
Tormo N; Solano C; de la Cámara R; Garcia-Noblejas A; Cardeñoso L; Clari MA; Nieto J; López J; Hernández-Boluda JC; Remigia MJ; Benet I; Navarro D
Biol Blood Marrow Transplant; 2010 May; 16(5):653-61. PubMed ID: 20005968
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of human herpesvirus-6 in allogeneic hematopoietic stem cell transplant recipients in correlation with cytomegalovirus infection].
Wang LR; Dong LJ; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1204-9. PubMed ID: 17204195
[TBL] [Abstract][Full Text] [Related]
5. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
Wang LR; Dong LJ; Zhang MJ; Lu DP
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
[TBL] [Abstract][Full Text] [Related]
6. HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.
Quintela A; Escuret V; Roux S; Bonnafous P; Gilis L; Barraco F; Labussière-Wallet H; Duscastelle-Leprêtre S; Nicolini FE; Thomas X; Chidiac C; Ferry T; Frobert E; Morisset S; Poitevin-Later F; Monneret G; Michallet M; Ader F;
J Infect; 2016 Feb; 72(2):214-22. PubMed ID: 26518057
[TBL] [Abstract][Full Text] [Related]
7. [How to manage EBV reactivation and EBV-PTLD, CMV and human herpesvirus 6 reactivation and infection after allogeneic stem cell transplantation: A report of the SFGM-TC (update)].
Brissot E; Alsuliman T; Gruson B; Hermet E; Tirefort Y; Yakoub-Agha I; Alain S
Bull Cancer; 2017 Dec; 104(12S):S181-S187. PubMed ID: 29169653
[TBL] [Abstract][Full Text] [Related]
8. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
[TBL] [Abstract][Full Text] [Related]
9. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
[TBL] [Abstract][Full Text] [Related]
10. Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation.
Jaskula E; Dlubek D; Sedzimirska M; Duda D; Tarnowska A; Lange A
Transplant Proc; 2010 Oct; 42(8):3273-6. PubMed ID: 20970670
[TBL] [Abstract][Full Text] [Related]
11. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotype.
Sobecks RM; Askar M; Thomas D; Rybicki L; Kalaycio M; Dean R; Avery R; Mossad S; Copelan E; Bolwell BJ
Exp Clin Transplant; 2011 Feb; 9(1):7-13. PubMed ID: 21605017
[TBL] [Abstract][Full Text] [Related]
13. Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - A single center 11-year analysis.
Düver F; Weißbrich B; Eyrich M; Wölfl M; Schlegel PG; Wiegering V
PLoS One; 2020; 15(2):e0228451. PubMed ID: 32017805
[TBL] [Abstract][Full Text] [Related]
14. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.
Borchers S; Luther S; Lips U; Hahn N; Kontsendorn J; Stadler M; Buchholz S; Diedrich H; Eder M; Koehl U; Ganser A; Mischak-Weissinger E
Transpl Infect Dis; 2011 Jun; 13(3):222-36. PubMed ID: 21585633
[TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation.
Jeulin H; Agrinier N; Guery M; Salmon A; Clément L; Bordigoni P; Venard V
Transplantation; 2013 May; 95(10):1292-8. PubMed ID: 23514960
[TBL] [Abstract][Full Text] [Related]
16. Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients.
Wang FZ; Larsson K; Linde A; Ljungman P
Bone Marrow Transplant; 2002 Oct; 30(8):521-6. PubMed ID: 12379892
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis.
Kampouri E; Zamora D; Kiem ES; Liu W; Ibrahimi S; Blazevic RL; Lovas EA; Kimball LE; Huang ML; Jerome KR; Ueda Oshima M; Mielcarek M; Zerr DM; Boeckh MJ; Krantz EM; Hill JA
Clin Microbiol Infect; 2023 Nov; 29(11):1450.e1-1450.e7. PubMed ID: 37532126
[TBL] [Abstract][Full Text] [Related]
18. Detection of beta-herpesviruses in allogenic stem cell recipients by quantitative real-time PCR.
Sassenscheidt J; Rohayem J; Illmer T; Bandt D
J Virol Methods; 2006 Dec; 138(1-2):40-8. PubMed ID: 16956672
[TBL] [Abstract][Full Text] [Related]
19. Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.
Aoki J; Numata A; Yamamoto E; Fujii E; Tanaka M; Kanamori H
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2017-22. PubMed ID: 26226409
[TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus-6 DNAemia is a sign of impending primary CMV infection in CMV sero-discordant renal transplantations.
Van Leer-Buter CC; Sanders JS; Vroom HE; Riezebos-Brilman A; Niesters HG
J Clin Virol; 2013 Oct; 58(2):422-6. PubMed ID: 23938304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]